As the Executive Vice-President of R&D at Mediphage Bioceuticals, Dr. Nafiseh Nafissi’s research focuses on developing innovative solutions for genetic and infectious diseases that have limited, or no treatment options. Dr. Nafissi is the co-inventor of ministring DNA (msDNA), platform technology, which has been designed to overcome critical challenges facing viral gene therapies and leverage advancements of non-viral gene therapy technologies.
